Dodatne informacije

• Lični podaci

• Datum rođenja: 16.08.1981.
• Mesto rođenja: Pančevo

• Obrazovanje

• Fakultet: Medicinski fakultet
• Odsek / Grupa / Smer: Medicina

• Spisak publikacija

• Monografije i poglavlja u monografijama:

  1. Крстић М, Стојнев С. Лимфоми гастроинтестиналног тракта. 1. изд. – Ниш: Медицински факултет Универзитета у Нишу: Свен, 2022. ИСБН 978-86-6265-108-2 (МФУ) (М42)

• Knjige i udžbenici:
  
  
  1. Стојнев С. Хемодинамски поремећаји. 49-56. У: Практикум из патохистологије. Маја Јовичић Милентијевић (уредник) – Београд: Дата Статус, 2022. ИСБН 978-86-7478-837-0 (М47)
  
  
  2. Стојнев С. Имунски посредоване болести. 57-64. У: Практикум из патохистологије. Маја Јовичић Милентијевић (уредник) – Београд: Дата Статус, 2022. ИСБН 978-86-7478-837-0 (М47)
  
  
  3. Stojnev S. Haemodynamic disturbances. 49-56. In: Histopathology practicum. Maja Jovičić Milentijević (editor) – Belgrade: Data status, 2023. ISBN 978-86-7478-952-0 
  
  
  4. Stojnev S. Immune mediated disorders. 57-64. In: Histopathology practicum. Maja Jovičić Milentijević (editor) – Belgrade: Data status, 2023. ISBN 978-86-7478-952-0 
  
  
  5. Глигоријевић Ј, Стојнев С. Интрацелуларно накупљање материја. У: Кутлешић Ч (Уредник). Патологија. Уџбеник за студенте основних струковних студија. Ниш: Галаксија; 2010: 25-29.(М44)
  
  
• Radovi u časopisima sa IMPACT faktorom:
  
  
  1. Janković Veličković L, Ristić Petrović A, Dolićanin Z, Stojnev S, Veličković F, Basić D. Expression of Basal Compartment and Superficial Markers in Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy, a Worldwide Disease. Biomedicines. 2024 Jan 1;12(1):95. doi: 10.3390/biomedicines12010095. IF: 4.757 IF5: 5.225 (M22)
  
  
  2. Stojanović N, Mitić K, Stojnev S, Sokolović D, Vukelić Nikolić D, Tričković-Vukić D, Randjelović P, Krstić M, Radulović N. Functioning of whole bone marrow cell population in a model of L-arginine-induced pancreatitis. European J Inflamm 2023; 21. IF: 0.700 IF5: 0.7 (M23)
  
  
  3. Todorović K, Stojiljković N, Ilić S, Stojanović N, Todorović A, Stojnev S, Mitić A, Spasić M, Jovanović M. Curcumin nanoliposomes mitigate wound tissue inflammatory response caused by tooth extraction. Braz J Pharm Sci 2022; 58. IF: 1.300 IF5: 1.7 (M23)
  
  
  4. Ristic Petrovic A, Stokanović D, Stojnev S, Potić Floranović M, Krstić M, Djordjević I, Skakić A, Janković Veličković L. The association between NOTCH3 expression and the clinical outcome in the urothelial bladder cancer patients. Bosn J Basic Med Sci2022;22(4):523-530. doi: 10.17305/bjbms.2021.6767. IF2 3.759 IF5 3.681 (M22)
  
  
  5. Krstic M*, Stojnev S*, Petkovic I, Conic I, Zujovic J, Milosevic V (*These authors contributed equally to this work).  Pathomorphological and clinical features of diffuse large B-cell lymphoma in Southeastern Serbia – seven-year experience at a tertiary center.J BUON 2021; 26(6): 2546-2553. ISSN: 1107-0625, online ISSN: 2241-6293.  IF2 2.533 IF5 1.987 (M23)
  
  
  6. Conic I, Nedovic B, Stojnev S, Todorovska I, Dimitrijevic A, Krstic M, Djordjevic I, Djordjevic B. Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort. Medicina (Kaunas) 2022; 58(5):607. doi: 10.3390/medicina58050607. IF: 2.948 IF5 2.9 (M22)
  
  
  7. Petković I, Stojnev S, Popović A, Krstić M, Pejčić I. EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression. Indian J Hematol Blood Transfus 2021; 37(4):694-696. doi: 10.1007/s12288-021-01425-w. IF: 0.900 IF5 1.026 (M23)
  
  
  8. Todorović K, Stojiljković N, Ilić S, Stojnev S, Todorović A, Stojanović S, Obradović R, Jovanović N. Immunohistochemical determination of osteopontin expression in tooth extraction wound tissue inflammatory cells–the effects of coenzyme Q10. Acta Microscopica 2021; 30(2):32-40. IF: 0.822 (M23)
  
  
  9. Petković I, Stojnev S, Popović A, Krstić M, Pejčić I. Extranodal NK/T–cell lymphoma, nasal type overlapping aggressive NK–cell leukemia in course of progression. Turkish Journal of Hematology and Oncology (UHOD-Uluslar Hematol) 2020; 30(4):248-51. doi:10.4999/uhod.204767. IF: 2.323 IF5: 2.019 (M23)
  
  
  10. Stojnev S, Krstić M, Čukuranović Kokoris J, Conić I, Petković I, Ilić S, Milosević-Stevanović J, Janković Veličković L. Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer. Medicina (Kaunas) 2019; 55(6):302. https://doi.org/10.3390/medicina55060302. IF: 2.430 IF5: 2.461 (M22)
  
  
  11. Krstić M, Stojanović NM, Stojnev S, Radenković G, Čukuranović Kokoris J, Mladenović B, Janković Veličković L. Interplay between STAT3, Cell Adhesion Molecules and Angiogenesis-Related Parameters in Gastric Carcinoma. Does STAT3 Really Have a Prognostic Value? Medicina (Kaunas) 2019; 55(6):300. https://doi.org/10.3390/medicina55060300. IF: 2.430 IF5: 2.461 (M22)
  
  
  12. Stojiljković N, Ilić S, Stojanović N, Janković-Veličković L, Stojnev S, Kocić G, Radenković G, Arsić I, Stojanović M, Petković M. Nanoliposome-encapsulated ellagic acid prevents cyclophosphamide-induced rat liver damage. Mol Cell Biochem 2019; doi: 10.1007/s11010-019-03541-8. IF: 2.884 IF5: 3.282 (M23)
  
  
  13. Milosevic-Stevanovic J, Krstic M, Stefanovic M, Zivadinovic R, Vukomanovic P, Pop Trajkovic-Dinic S, Stojnev S. T lymphocytes in the third trimester decidua in preeclampsia. Hypertens Pregnancy 2019; 38(1):52-7. doi:10.1080/10641955.2019.1575393. IF: 1.787 IF5: 1.775 (M23)
  
  
  14. Stojiljkovic N, Ilic S, Jakovljevic V, Stojanovic NM, Stojnev S,  Kocic H,  Stojanovic M,  Kocic G. The encapsulation of lycopene in nanoliposomes enhances its protective potential in methotrexate-induced kidney injury model. Oxid Med Cell Longev 2018; https://doi.org/10.1155/2018/2627917. IF: 5.076 IF5: 7.454 (M21)
  
  
  15. Potic-Floranovic M, Ristic-Petrovic A, Stojnev S, Potic M, Petrovic F, Jankovic-Velickovic Lj. Large-cell calcifying Sertoli cell tumour with macrocalcification in partially resected testis of young adult patient. Malays J Pathol 2018; 40(3):343-8. IF: 0.656 IF5: 0.786 (M23)
  
  
  16. Petković I, Pejčić I, Tiodorović D, Krstić M, Stojnev S, Vrbić S. Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B–cell lymphoma of other type. Postep Derm Alergol 2017; 34(6):625-28. doi:10.5114/pdia.2017.66625 IF: 1.683 IF5: 1.407 (M22)
  
  
  17. Mitić A, Todorović K, Stojiljković N, Stojanović N, Ilić S, Todorović A, Stojnev S. Beneficial effects of curcumin on the wound-healing process after tooth extraction. Nat Prod Commun 2017; 12:1905-08.doi.org/10.1177/1934578X1701201223. IF: 0.809 IF5: 0.899 (M23)
  
  
  18. Todorović K, Jovanović G, Todorović А, Mitić A, Stojiljković N, Ilić S, Stojanović N, Stojnev S. Effects of coenzyme Q10 encapsulated in nanoliposomes on wound healing processes after tooth extraction. J Dent Sci 2017; doi.org/10.1016/j.jds.2017.10.004. IF: 0.798 IF5: 0.874 (M23)
  
  
  19. Krstić M, Gabrielli S, Ignjatović M, Savić S, Cancrini G, Ranđelović G, Momčilović S, Stojnev S, Otašević S. An appraisal of canine and human cases reveals an endemic status of dirofilariosis in parts of Serbia. Mol Cell Probes 2017; 31:37-41.  http://dx.doi.org/10.1016/j.mcp.2016.08.005. IF: 1.689 IF5: 1.494 (M23)
  
  
  20. Milosevic Stevanovic J, Krstic M, Radovic Janosevic D, Popovic J, Tasic M, Stojnev S. Number of decidual natural killer cells and macrophages in preeclampsia. Indian J Med Res 2016; 144(6):823-30.  doi: 10.4103/ijmr.IJMR_776_15.  IF: 1.532 IF5: 2.166 (M22)
  
  
  21. Popovska-Jankovic K, Noveski P, Jankovic-Velickovic L, Stojnev S, Cukuranovic R, Stefanovic V, Toncheva D, Staneva R, Polenakovic M, Plaseska-Karanfilska D. MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy. Biomed Res Int 2016; 2016: 7450461. doi: 10.1155/2016/7450461. IF: 2.583 IF5: 2.931 (M22)
  
  
  22. Stojnev S, Krstic M, Ilić I, Petković I, Stojanović S, Cvetković P, Randjelović P, Veličković Lj. Acute myocardial infarction associated with Trousseau's syndrome: case report and review of the literature. W Indian Med J 2016; doi: 10.7727/wimj.2016.140. IF: 0.332 IF5: 0.414 (M23)
  
  
  23. Petković I, Stojnev S, Krstić M, Pejčić I, Vrbić S. Synchronous mantle cell lymphoma and prostate adenocarcinoma - is it just a coincidence? Vojnosanit Рregl 2016; 73(11):  1072-75. doi:10.2298/VSP150425125P IF: 0.367 IF5: 0.382 (M23)
  
  
  24. Stojnev S, Krstić M, Janković Veličković Lj, Ristić Petrović A, Milojković M, Jovanović I, Stokanović D, Ugrenović S. Impact of Ki-67 and E-cadherin expression on lymphovascular invasion in upper urinary tract urothelial carcinoma. Vojnosanit Pregl 2015; 72(11):982-88. doi: 10.2298/VSP140605101S. IF: 0.355 IF5: 0.403 (M23)
  
  
  25. Conic I, Stanojevic Z, Jankovic Velickovic Lj, Stojnev S, Ristic Petrovic A, Krstic M, Stanojevic M, Bogdanović D, Stefanovic V. Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy. J Obstet Gynaecol Res 2015; 41(10):1630-7. doi: 10.1111/jog.12758. IF:1.091 IF5: 1.057 (M23)
  
  
  26. Stefanovic V, Cukuranovic R, Dolicanin Z, Cukuranovic J, Stojnev S, Bogdanovic D, Rajic M, Kocic G. Placental growth factor and placental protein 13 in patients with Balkan endemic nephropathy, a worldwide disease. Renal Failure 2015; 37(7):1145-8. doi: 10.3109/0886022X.2015.1061870. IF: 0.944 IF5: 0.936 (M23)
  
  
  27. Stojnev S, Krstic M, Ristic-Petrovic A, Stefanovic V, Hattori T. Gastric cancer stem cells: therapeutic targets. Gastric Cancer 2014; 17(1):13-25. doi: 10.1007/s10120-013-0254-x. IF: 4.828 IF5: 5.970 (M21)
  
  
  28. Stojnev S, Ristic-Petrovic A, Jankovic Velickovic Lj, Krstic M, Bogdanovic D, Khanh Do T, Ristic A, Conic I, Stefanovic V. Prognostic significance of mucin expression in urothelial bladder cancer. Int J Clin Exp Pathol 2014; 7(8):4945-58. PMCID: PMC4152056. IF: 2.242 IF: 2.249 (M22)
  
  
  29. Petkovic I, Krstic M, Pejcic I, Vrbic S, Stojnev S, Cvetanovic A, Balic M, Todorovic M. Renal Infiltration of Follicular Lymphoma. Turk J Hematol 2014; 31:315-6. doi: 10.4274/Tjh.2014.0013. IF: 0.360 IF5: 0.359 (M23)
  
  
  30. Stevanovic I, Ninkovic M, Stojanovic I, Ljubisavljevic S, Stojnev S, Bokonjic D. Beneficial effect of agmatine in the acute phase of experimental autoimmune encephalomyelitis in INOS-/-knockout mice. Chemico-Biological Interactions 2013; 206 (2):309-318.doi: 10.1016/j.cbi.2013.09.006. IF: 2.982 IF5: 3.154 (M21)
  
  
  31. Krstic M, Stojnev S, Jovanovic I, Marjanovic G. KLF4 expression and apoptosis-related markers in gastric cancer. J BUON 2013; 18(3): 695-702. PMID: 24065485. IF: 0.761 IF5: 0.673 (M23)
  
  
  32. Krstić M, Katić V, Stojnev S, Mihailović D, Mojsilović M, Radovanović Z, Živković V. Peutz-Jeghers syndrome: quantitative study on enterochromaffin cells in hamartomatous intestine polyps. Srp Arh Celok Lek 2013; 141(9-10):602-7. PMID: 24364221. IF: 0.228 IF5: 0.208 (M23)
  
  
  33. Stojnev S, Ristić-Petrović A, Janković-Veličković Lj. Reactive oxygen species, apoptosis and cancer. Vojnosanit Pregl 2013; 70(7):675–8. doi: 10.2298/VSP1307675S. IF: 0.269 IF5: 0.310 (M23)
  
  
  34. Ristić-Petrović A, Stojnev S, Janković-Veličković Lj. Malakoplakia mimics urinary bladder cancer: a case report. Vojnosanit Pregl 2013; 70(6):606-8. https://doi.org/10.2298/VSP1306606R. IF: 0.269 IF5: 0.310 (M23)
  
  
  35. Jankovic-Velickovic Lj, Dimov I, Petrovic D, Stojnev S, Dacic S, Velickovic S, Stevanovic V. Stromal reaction and prognosis in acinic cell carcinoma of the salivary gland. Vojnosanit Pregl 2013; 70(12):1155–8. doi:10.2298/vsp1312155j. IF: 0.269 IF5: 0.310 (M23)
  
  
  36. Ljubisavljevic S, Stojanovic I, Pavlovic R, Stojnev S, Stevanovic I, Sokolovic D, Pavlovic D. The reduced glutathione and s-nitrosothiols levels in acute phase of experimental demyelination – pathophysiological approach and possible clinical relevancy. Neuroscience 2012; 219: 175-82.doi: 10.1016/j.neuroscience.2012.05.062. IF: 3.380 IF5: 3.458 (M22)
  
  
  37. Jankovic-Velickovic Lj, Ristic-Petrovic A,  Stojnev S, Dolicanin Z, Hattori T, Sugihara H, Mukaisho K, Stojanovic M, Stefanovic V. Angiogenesis in upper tract urothelial carcinoma associated with balkan endemic nephropathy. Int J Clin Exp Pathol 2012; 5(7): 674-83. PMCID: PMC3438770. IF: 2.242 IF5: 2.249 (M22)
  
  
  38. Milojković M, Stojnev S, Jovanović I, Ljubisavljević S, Stefanović V, Sunder-Plassman R. Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the serbian population. Pharmacological Reports 2011; 63(3): 808-14. PMID: 21857092. IF: 2.500 IF5: 2.386 (M22)
  
  
  39. Janković Veličković LJ, Stojnev S, Ristić-Petrović A, Dolićanin Z, Hattori T, Mukaisho K, Stojanović M, Stefanović V. Pro and antiapoptotic markers in upper tract urothelial carcinoma associated with balkan endemic nephropathy. The Scientific World Journal 2011; 11: 1699-711. doi: 10.1100/2011/752790. IF: 1.658 (М21)
  
  
  40. Pejčić M, Stojnev S, Stefanović V. Urinary proteomics – a tool for biomarker discovery. Renal Failure 2010; 32(2): 259-268. doi: 10.3109/08860221003599759. IF: 0.840 IF5: 1.020 (M23)
  
  
  41. Stojnev S, Pejčić M, Dolićanin Z, Janković-Veličković Lj, Dimov I, Stefanović V. Challenges of genomics and proteomics in nephrology. Renal Failure 2009; 31(8): 765-772.doi: 10.3109/08860220903100713. IF: 0.840 IF5: 1.020 (M23)
  
  
• Radovi u ostalim časopisima:
  
  
  1. Stojnev S, Ristić Petrović A, Radić M, Janković Veličković Lj. Predictive value of Claudin-4 expression in non-muscle invasive urothelial bladder cancer. Acta Medica Medianae 2024; doi:10.5633/amm.2024.0413.
  
  
  2. Krstić M, Stojnev S, Petković I. Mantle cell lymphoma – a killer with a child’s face. Acta Medica Medianae 2022; 61(1):23-29.
  
  
  3. Ilic S, Mitić N, Stojnev S, Stojanovic M, Stojiljkovic N. Coenzyme Q10 attenuates methotrexate-induced liver injury in rats. Acta Medica Medianae 2022; 61(3):93-100.
  
  
  4. Conić I, Stojnev S, Dimitrijević A, Jankovič-Veličković Lj, Djordjević B, Djordjević I, Pejčić I, Vrbić S. Clinical significance of CD44 expression in serous ovarian cancer. Acta Medica Medianae 2020;59(4):26-33. doi:10.5633/amm.2020.0404
  
  
  5. Ristić-Petrović A, Stokanovic D, Krtinic D, Potic Floranovic M, Stojnev S, Janković Veličković Lj. An immunohistochemical analysis of vascular endothelial growth factor receptor 1 in high grade T1 bladder cancer with concomitant carcinoma in situ. Acta Medica Medianae 2019; 58(4):05-11. doi: 10.5633/amm.2019.0401.
  
  
  6. Stojnev S, Ristić A, Krstić M, Ristić-Petrović A, Conić I, Petković I, Milenković J, Janković Veličković Lj. Expression of epigenetic silencer EZH2 in early invasive pT1 urothelial bladder cancer. Acta Medica Medianae 2018; 57(3):48-54. doi: 10.5633/amm.2018.0306.
  
  
  7. Krstić M, Stojnev S, Milenković N. The correlation between KLF4 expression and cell adhesion molecules in gastric cancer. Acta Medica Medianae 2017; 56(3):143-150. doi: 10.5633/amm.2017.0322.
  
  
  8. Petković I, Krstić M, Stojnev S, Pejčić I, Vrbić S. Extensive Bone Marrow Involvement in Hodgkin Lymphoma Patient. Acta Facultatis Medicae Naissensis 2014; 31(4): 263-267.
  
  
  9. Stojanović I, Ljubisavljević S, Stevanović I, Stojnev S, Pavlović R, Sokolović D, Petrović A, Pavlović D, Cvetković T. Benefit Agmatine Effects in Experimental Multiple Sclerosis. CNS Nitrosative and Oxidative Stress Suppression. Acta Facultatis Medicae Naissensis 2014; 31(4): 233-243.
  
  
  10. Mijović Ž, Pešić Z, Živković N, Denčić T, Petrović AR, Stojnev S. Karyometric Analysis of Squamous Metaplasia, Dysplasia and Squamous Cell Carcinoma of the Lung. Acta Facultatis Medicae Naissensis 2014; 31(3): 177-182.
  
  
  11. Krstić M, Stojnev S. Cancer stem cells - current concepts, therapeutic implications and challenges. Materia Medica 2014; 30(2): 1140-6.
  
  
  12. Radovic J, Markovic D, Velickov A, Djordjevic B, Stojnev S. Vitamin D immunomodulatory effect. Acta Medica Medianae 2012; 51(4): 58-64.
  
  
  13. Stojnev S, Golubović M, Babović P. TP53 mutations – from the guardian of the genome to oncogene. Acta Medica Medianae, 2010; 49(1): 59-63.
  
  
• Radovi na naučnim skupovima međunarodnog značaja:
  
  
  1. Stojnev S, Krstic M, Ristic Petrovic A, Conic I, Petkovic I, Todorovic J, Mladenovic M, Jankovic Velickovic Lj. Prognostic significance of death receptors expression in primary and recurrent T1 bladder cancer. Virchows Arch 2023; 483 (Suppl 1): S143. The 35th European Congress of Pathology, 9 – 13 September 2023, Dublin, Ireland.IF: 4.548
  
  
  2. Stojnev S, Krstic M, Ristic Petrovic A, Conic I, Petkovic I, Lilić B, Jevtić M, Vučić M. Smouldering systemic mastocytosis with the development of striking osteosclerosis. Virchows Arch 2023; 483 (Suppl 1): S143. The 35th European Congress of Pathology, 9 – 13 September 2023, Dublin, Ireland.IF: 4.548
  
  
  3. Ristic Petrovic A, Stojnev S, Potic Floranovic, Conic I, Krstic M, Jankovic-Velickovic Lj. Predictors of cancer-specific mortality in pT1 urothelial bladder cancer: 50 months follow-up in 284 cases. Virchows Arch 2023; 483 (Suppl 1): S143. The 35th European Congress of Pathology, 9 – 13 September 2023, Dublin, Ireland. IF: 4.548
  
  
  4. Krstić M, Stojnev S. Eozinofil: od nevinog posmatrača do protagoniste. 17. Nacionalni kongres Udruženja patologa i citologa Srbije sa međunarodnim učešćem, 12-16. maj 2022, Zlatibor, Srbija. Materia Medica 2022; 38 (Suppl.1): 125-7.
  
  
  5. Stojnev S, Ristic Petrovic A, Janković Veličković Lj, Krstic M. Transformišući faktor rasta beta 1 u urotelnom karcinomu mokraćne bešike. Nacionalni kongres Udruženja patologa i citologa Srbije sa međunarodnim učešćem, 12-16. maj 2022, Zlatibor, Srbija. Materia Medica 2022; 38 (Suppl.1): 11-12.  M34
  
  
  6. Ristic Petrovic A, Stojnev S, Krstic M, Janković Veličković Lj. NOTCH3 expression in the clinical follow-up of the urothelial bladder cancer patients. Nacionalni kongres Udruženja patologa i citologa Srbije sa međunarodnim učešćem, 12-16. maj 2022, Zlatibor, Srbija. Materia Medica 2022; 38 (Suppl.1): 18-21.  M34
  
  
  7. Stojnev S, Krstic M, Ristic A,Petkovic I, Conic I, Ristic-Petrovic A,Todorovic J, Mladenovic M.Association of STAT3 expression and enhanced angiogenesis in primary extranodal diffuse large B cell lymphoma. Virchows Archiv 2021; 479 (Suppl 1): S116. The 33rd Congress of Pathology, 29 – 31 August 2021, virtual. https://doi.org/10.1007/s00428-021-03157-8. IF: 2.906
  
  
  8. Stojnev S, Krstic M, Ristic-Petrovic A, Jankovic Velickovic L, Conic I, Todorovic J, Mladenovic M, Ristic A.Decreased FAS expression predicts poor survival in muscle-invasive bladder cancer. Virchows Archiv 2021; 479 (Suppl 1): S177. The 33rd Congress of Pathology, 29 – 31 August 2021, virtual. https://doi.org/10.1007/s00428-021-03157-8. IF: 2.906
  
  
  9. Todorovic J, Mladenovic M, Shekhsaidov I, Harding U, Stojnev S, Reinecke-Luethge A. A rare case of aggressive basal cell carcinoma of the prostate with infiltration of the urinary bladder. Virchows Archiv 2021; 479 (Suppl 1): S318. The 33rd Congress of Pathology, 29 – 31 August 2021, virtual. https://doi.org/10.1007/s00428-021-03157-8.
  
  
  10. Todorovic J, Jahn B, Mladenovic M, Sroczynski G, Rochau U, Puntscher S, Santamaria J, Allende V, Oefner D, Ferlitsch M, Haider K, Greuter M, Coupe V, Stojnev S, Siebert U.Fecal Immunochemical Tests for Colorectal Cancer Screening How Adenoma Characteristics Impact Test Sensitivity: a Systematic Review and Meta-Analysis.Medical Decision Making 2021; 41(4): E171.
  
  
  11. Stojnev S, Ristic A, Krstic M, Ristic-Petrovic A, Conic I, Todorovic J, Mladenovic M, Jankovic Velickovic L. An immunohistohemical study of transforming growth factor beta-1 expression in urothelial bladder cancer and its prognostic significance. Virchows Arch 2020; 477 (Suppl 1): S169. The 32nd Congress of the ESP and XXXIII International Congress of the IAP, 6 – 8 December 2020, Glasgow, United Kingdom. https://doi.org/10.1007/s00428-020-02938-x IF: 2.906
  
  
  12. Ristic-Petrovic A, Stojnev S, Stokanovic D, Potic Floranovic M, Djordjevic I, Velickovic L.The significance of the NOTCH3 expression in the urothelial bladdercancer patients’ follow-up. Virchows Arch 2020; 477 (Suppl 1): S167.The 32nd Congress of the ESP and XXXIII International Congress of the IAP, 6 – 8December 2020, Glasgow, United Kingdom. https://doi.org/10.1007/s00428-020-02938-x IF: 2.906
  
  
  13. Conic I, Stojnev S, Jankovic Velickovic L, Djordjevic B, Dimitrijevic A, Krstic M, Ristic Petrovic A, Djordjevic I, Krtinic D. Sox2 expression in ovarian serous epithelial cancer. Int J Gynecol Cancer 2020; 30 (Suppl 4):A1–A119. ESGO SoA 2020 Conference Abstracts. IF: 2.095
  
  
  14. Todorovic J, Jahn B, Mladenovic M, Sroczynski G, Rochau U, Puntscher S,  Santamaria J, Allende V, Stojnev S, Siebert U. Colorectal cancer screening with fecal immunochemical tests – the impact of anatomical, morphological and histopathological adenoma characteristics on test sensitivity: systematic review and meta-analysis. Oncol Res Treat 2020; 43(suppl 1) pp.54/54. VII–265. 34. Allschwilerstrasse 10, Ch-4009 Basel, Switzerland: Karger. Deutscher Krebskongress. Berlin, 19.–22. Februar 2020. IF: 1.967
  
  
  15. Ristic-Petrovic A, Stokanovic D, Stojnev S,  Potic Floranovic M, Djordjevic I, Jankovic-Velickovic Lj. An immunohistochemical analysis of HIF1 alpha and VEGFR1 in high grade T1 bladder cancer. Virchows Arch 2019; 475 (Suppl 1): S183. The 31st European Congress of Pathology, 7 – 11 September 2019, Nice, France. IF: 2.936
  
  
  16. Krstic M, Peruničić Jovanović M, Stojnev S, Jovanović P, Petković I, Antić D. Clinicopathologic analysis of splenic lymphoma: Three year experience. 19th Meeting of the European Association for Haematopathology - EAHP 2018 - Abstracts - Edinburgh, September 29 - October 4. 2018; LYS-P-64, p.134. URN: urn:nbn:de:101:1-18090814511117068414.
  
  
  17. Krstić M, Stojnev S. Risk factors for occurance of malignant neoplasms of lymphoid tissue. Book of abstracts, 52^nd days of Preventive Medicicne, International congress, 25 – 28. September 2018, Nis, Serbia.
  
  
  18. Stojnev S,  Krstic M, Ristic-Petrovic A, Jankovic-Velickovic Lj, Conic I,  Velickov A, Potic-Floranovic M, Mladenovic M, Todorovic J. Expression of death receptors DR4 and DR5 in non-muscle-invasive bladder cancer. Virchows Arch 2018; 473 (Suppl 1): S185. The 30th European Congress of Pathology, 8 – 12 September 2018, Bilbao, Spain. IF: 2.936
  
  
  19. Ristic-Petrovic A, Stojnev S, Stokanovic D, Potic-Floranovic M, Velickov A, Krstic M,  Conic I, Jankovic-VelickovicLj. An immunohistochemical analysis of angiogenesis in bladder cancer occurring in settlements linked with Balkan endemic nephropathy. Virchows Arch 2018; 473 (Suppl 1): S185. The 30th European Congress of Pathology, 8 – 12 September 2018, Bilbao, Spain. IF: 2.936
  
  
  20. Potic-Floranovic M, Ristic-Petrovic A, Jankovic-Velickovic Lj, Stojnev S, Velickov A. Large-cell calcifying Sertoli cell tumour with macrocalcification in partially resected testis of a young adult patient. Virchows Arch 2018; 473 (Suppl 1): S326. The 30th European Congress of Pathology, 8 – 12 September 2018, Bilbao, Spain. IF: 2.936
  
  
  21. Stojnev S, Krstić M, Ristic-Petrovic A, Conic I, Ristic A, Janković Veličkovic Lj. Prognostic significance of Ezh2 expression in superficial urothelial bladder cancer. Materia Medica 2018; 34 (1, Suppl 1): 53. 16th National SPCA Congress and 2nd International SPCA Congress, 18^th-21^st April, 2018, Zlatibor, Serbia.
  
  
  22. Ristic Petrovic A, Stojnev S, Krstic M, Stokanovic D, Jankovic Velickovic Lj. An immunohistochemical analysis of angiogenic profile in T1 bladder cancer with concomitant carcinoma “in situ”. Materia Medica 2018; 34 (1, Suppl 1): 5. 16th National SPCA Congress and 2nd International SPCA Congress, 18^th-21^st April, 2018, Zlatibor, Serbia.
  
  
  23. Conic I, Stojnev S, Jankovic-Velickovic Lj,  Djordjevic B,  Djordjevic I,  Ristic-Petrovic A,  Krtinic D,  Krstic M. The role of CD44 in ovarian cancer. Int J Gynecol Cancer 2017; 27 (Suppl 4): 1928. IF: 2.192
  
  
  24. Stojnev S, Krstic M, Ristic A, Todorovic J, Mladenovic M, Ristic-Petrovic A, Conic I, Jankovic Velickovic Lj. Correlation between expression of epigenetic silencer EZH2 and Claudin-4 and their prognostic value in urothelial bladder cancer - immunohistochemical study. Virchows Arch 2017; 471 (Suppl 1):S29. OFP-09-012. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 29th European Congress of Pathology, 2 – 6 September 2017, RAI Amsterdam, The Netherlands. IF: 2.936
  
  
  25. Stojnev S, Ristic-Petrovic A, Krstic M, Mladenovic M, Todorovic J, Petkovic I, Jankovic Velickovic Lj. Expression of stemness markers Oct3/4 and Nanog in early invasive T1 urothelial bladder cancer. Virchows Arch 2017; 471 (Suppl 1): S280-81. PS-25-080. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 29th European Congress of Pathology, 2 – 6 September 2017, RAI Amsterdam, The Netherlands. IF: 2.936
  
  
  26. Jankovic Velickovic Lj, Ristic Petrovic A, Stojnev S, Velickovic F, Bankovic S. Expression of stem related markers-Sox2 and Oct3/4 in upper tract urothelial carcinoma. Virchows Arch 2017; 471 (Suppl 1): S279. PS-25-072. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 29th European Congress of Pathology, 2 – 6 September 2017, RAI Amsterdam, The Netherlands. IF: 2.936
  
  
  27. Ristic-Petrovic A, Stojnev S, Stokanovic D, Krstic M, Velickov A, Kostic J, Jankovic Velickovic Lj. Immunohistochemical evaluation of angiogenic activity in noninvasive (pTa) bladder cancer. Virchows Arch 2017; 471 (Suppl 1): S266. PS-25-011. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 29th European Congress of Pathology, 2 – 6 September 2017, RAI Amsterdam, The Netherlands. IF: 2.936
  
  
  28. Velickov A, Radenkovic G, Petrovic V, Ristic Petrovic A, Stojnev S. Alterations of interstitial cells of Cajal (ICC) in the rat colon in diabetes. Virchows Arch 2017; 471 (Suppl 1): S193. PS-13-088. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 29th European Congress of Pathology, 2 – 6 September 2017, RAI Amsterdam, The Netherlands. IF: 2.936
  
  
  29. Stojnev S, Krstic M, Mladenovic M, Todorovic J, Ristic-Petrovic A, Conic I, Stojanovic S, Jankovic Velickovic Lj. Prognostic impact of p63 and Beta-catenin coexpression in urothelial bladder cancer. Virchows Arch 2016; 469 (Suppl 1):S15. OFP-05-011. The XXXI International Congress of International Academy of Pathology and 28th Congress of the European Society of Pathology, September 25-29^th 2016, Cologne, Germany. IF: 2.848
  
  
  30. Ristic-Petrovic A, Stojnev S, Stokanovic D, Conic I, Krstic M, Stojanovic S, Zivkovic N, Dencic T, Zivkovic V, Jankovic Velickovic Lj. Predictive impact of angiogenesis and hypoxia related markers in urothelial bladder cancer. Virchows Arch 2016; 469 (Suppl 1):S15-S16. OFP-05-012.The XXXI International Congress of International Academy of Pathology and 28th Congress of the European Society of Pathology, September 25-29^th 2016, Cologne, Germany.  IF: 2.848
  
  
  31. Stojnev S, Krstic M, Todorovic J, Mladenovic M. Morphometric analysis of neoplastic and non-neoplastic lymphoid infiltrate in endoscopic biopsies of gastric mucosa. 18^th Meeting of the European Association for Haematopathology EAHP 2016; Program, LYS-P-61, p.42. September 3-8^th 2016, Basel, Switzerland.
  
  
  32. Krstic M, Stojnev S, Petkovic I. STAT3 expression in diffuse large B-cell lymphoma of nodal and extranodal localization. 18^th Meeting of the European Association for Haematopathology EAHP 2016; Program, LYS-P-75, p.45. September 3-8^th 2016, Basel, Switzerland.
  
  
  33. Krstic M, Stojnev S, Velickovic L. Signet-ring-cell variant of diffuse large B-cell lymphoma mimicking carcinoma. 18^th Meeting of the European Association for Haematopathology EAHP 2016; Program, LYS-P-76, p.45. September 3-8^th 2016, Basel, Switzerland.
  
  
  34. Stojnev S, Krstić M, Mladenović M, Todorović J, Ristić-Petrović A, Conić I, Janković-Veličković Lj. Koekspresija Beta-katenina i p63 u urotelnom karcinomu mokraćne bešike. Materia Medica 2016; 32 (2): 1469-70. Prvi Internacionalni kongres Udruženja patologa i citologa Srbije 21-23. April 2016.
  
  
  35. Stojnev S, Ristic-Petrovic А, Krstic М, Conic I, Jankovic Velickovic Lj. The expression of MUC2 and MUC6 predicts survival in urothelial bladder cancer. Virchows Arch 2015; 467(Suppl 1):S21–S22. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 27th European Congress of Pathology (ECP 2015), September 5-9^th 2015, Belgrade, Serbia. IF: 2.651
  
  
  36. Stojnev S, Krstic M, Zivkovic V, Gligorijevic J, Stojanovic I. Expression profile of antiapoptotic markers in gastric cancer. Virchows Arch 2015; 467(Suppl 1):S128–S129. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 27th European Congress of Pathology (ECP 2015), September 5-9^th 2015, Belgrade, Serbia. IF: 2.651
  
  
  37. Stojnev S, Krstic M, Zivkovic V, Ilic I, Mihailovic D. The correlation of mucin phenotype and Klf4 expression in gastric cancer. Virchows Arch 2015; 467(Suppl 1):S129. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 27th European Congress of Pathology (ECP 2015), September 5-9^th 2015, Belgrade, Serbia.  IF: 2.651
  
  
  38. Stojnev S, Ilic I, Krstic M, Stojanovic S, Dencic T, Zivkovic N, Mijovic Z. Trousseau's syndrome associated with lung adenocarcinoma presented as acute myocardial infarction. Virchows Arch 2015; 467(Suppl 1):S247. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 27th European Congress of Pathology (ECP 2015), September 5-9^th 2015, Belgrade, Serbia.  IF: 2.651
  
  
  39. Stojnev S, Jankovic Velickovic Lj, Ristic-Petrovic A, Stojanovic S, Jovicic Milentijevic M, Krstic M. Impact of Ki-67 and E-cadherin expression on lymphovascular invasion in upper urinary tract urothelial carcinoma. Virchows Arch 2015; 467(Suppl 1):S272. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 27th European Congress of Pathology (ECP 2015), September 5-9^th 2015, Belgrade, Serbia.  IF: 2.651
  
  
  40. Pešić I, Mueller GA, Stefanović V, Janković Veličković Lj, Ristić AV, Stojnev S, Bojanić V, Radović J, Đinđić B, Dihazi H. Ochratoxin A induce time and dose depended apoptosis and ER stress in human renal tubular epithelial cells: cell proteome analyses. 32^nd Balkan Medical Week; 21-23. sep 2012; Niš, Serbia.
  
  
  41. Ljubisavljević S, Stojanović I, Stojnev S, Stevanović I, Pavlović D, Milojković M, Bojanić V, Dunjić O, Radović J. The suppression of glial cells activity in the CNS ameliorates neurological expression in the experimental model of human multiple sclerosis. 32^nd Balkan medical week; Niš, Serbia, September 2012: p176.
  
  
  42. Milojković M, Stojnev S, Bojanić Z, Bojanić V. The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome and type 2 diabetes in patients from south-east Serbia. Archives of the Balkan Medical Union 2011; 46(Suppl 1).
  
  
  43. Milojković M, Stojnev S, Ljubisavljević S, Mušović D, Dunjić O, Sunder-Plassmann R. Frequency of C1236T, G2677T/A and 3435T MDR1 gene polymorphisms in Serbian population. Abstract book; 2nd Congress of physiological sciences of Serbia with international participation, Kragujevac 2009.
  
  
• Radovi na domaćim naučnim skupovima:
  
  
  1. Conić I, Stojnev S, Petković I, Krtinić D, Radić M. Serous adenocarcinoma of the ovary with bone metastasis - A rare case report. Abstract Book. 60. Kancerološka nedelja, Beograd 2023.
  
  
  2. Stojnev S, Krstić M, Petković I, Conić I, Ristić Petrović A. Patohistološki aspekti limfoma gastrointestinalnog trakta. Program i knjiga sažetaka Simpozijuma Srpskog Lekarskog Društva „Multidisciplinarni pristup u dijagnostici i lečenju tumora dojke, cerviksa i digestivnog trakta“, pp, 14-15. ISBN 978-86-6061-151-4.Beograd, 2023.
  
  
  3. Ristić Petrović A, Stojnev S, Conić I, Krstić M. Značaj patohistološkog izveštaja u onkološkom praćenju pacijentkinja saranim i uznapredovalim karcinomom grlića materice. Program i knjiga sažetaka Simpozijuma Srpskog Lekarskog Društva „Multidisciplinarni pristup u dijagnostici i lečenju tumora dojke, cerviksa i digestivnog trakta“, pp, 10-11. ISBN 978-86-6061-151-4.Beograd, 2023.
  
  
  4. Conić I, Stojnev S, Krstić M, Ristić Petrović A, Petković I. Savremene terapijske opcije u lečenju bolesnica sa uznapredovalimkarcinomom grlića materice. Program i knjiga sažetaka Simpozijuma Srpskog Lekarskog Društva „Multidisciplinarni pristup u dijagnostici i lečenju tumora dojke, cerviksa i digestivnog trakta“, pp, 12-13. ISBN 978-86-6061-151-4.Beograd, 2023.
  
  
  5. Petković I,Stojnev S, Conić I, Radić M. Klinički aspekti limfoma gastrointestinalnog trakta. Program i knjiga sažetaka Simpozijuma Srpskog Lekarskog Društva „Multidisciplinarni pristup u dijagnostici i lečenju tumora dojke, cerviksa i digestivnog trakta“, pp, 16-17. ISBN 978-86-6061-151-4.Beograd, 2023.
  
  
  6. Petković I, Stojnev S, Popović A, Krstić M, Pejčić I. EBV negative angioimmunoblastic T-cell lymphoma with sequential development of diffuse large B-cell lymphoma in course of progression. Abstract Book pp, 144-5. 58. Kancerološka nedelja, Beograd 2021.
  
  
  7. Petković I, Stojnev S, Popović A, Krstić M, Džunić M, Pejčić I. Extranodal NK/T-cell lymphoma, nasal type overlapping aggressive NK-ccell leukemia in course od progression, rare entity – case report. Abstract Book pp, 142-3. 58. Kancerološka nedelja, Beograd 2021.
  
  
  8. Stojnev S, Conić I. Prognostički značaj ekspresije EZH2 u rano invazivnom T1 urotelnom karcinomu mokraćne bešike visokog histološkog gradusa. Abstract book: 42. The first national congress of the urological section of Serbian medical association and regional joint meeting September, 28-30^th, 2017, Belgrade, Serbia.
  
  
  9. Stojnev S, Stojanović I, Krstić M, Mladenović D. Imunohistohemijska ekspresija markera apoptoze u karcinomu želuca. Timočki medicinski glasnik 2015; 40(Suppl 1):30. ISSN 0350-2899 eISSN 2406-1042. XXXIV Timočki medicinski dani, Zaječar, 16–17. maj 2015.
  
  
  10. Krstić M, Stojnev S, Vidović N, Anđelković Matić M, Stojanović I, Mladenović D. Korelacija mucinskog fenotipa i ekspresije Klf4 u karcinomu želuca. Timočki medicinski glasnik 2015; 40(Suppl 1):38. ISSN 0350-2899 eISSN 2406-1042. XXXIV Timočki medicinski dani, Zaječar, 16–17. maj 2015.
  
  
  11. Stojanović I, Mladenović D, Stojnev S. Maligni melanoma uterusa, cerviksa i jajnika–prikaz slučaja. Timočki medicinski glasnik 2015; 40(Suppl 1):57. ISSN 0350-2899 eISSN 2406-1042. XXXIV Timočki medicinski dani, Zaječar, 16–17. maj 2015.
  
  
  12. Krstić M, Stojnev S, Petković I, Vrbić S, Pejčić I. Ekspresija Stat3 u difuznom B-krupnoćelijskom limfomu nodalne i ekstranodalne lokalizacije.  Knjiga sažetaka; P55:157. 3. Kongres hematologa Srbije, Kragujevac, 12-15. novembar 2015.
  
  
  13. Conić I, Lilić R, Stanojević Z, Stojnev S. Efikasnost pregabalina u kombinaciji sa opijatima u lečenju neuropatskog bola - prikaz slučaja. Udruženje zai straživanje i tretman bola Srbije (UITBS) I Deutsche Schmerzgesellschafte.V. (DGSS). April 2015.
  
  
  14. Conić I, Stanojević Z, Filipović S, Pejčić I, Stojnev S, Vrbić S. Uticaj vrste terapije karcinoma grlića materice na kvalitet života bolesnica. 51. Kancerološka nedelja. Beograd 2014, 46: O16.
  
  
  15. Conic I, Stanojevic Z Filipovic S, Stojnev S, Pejcic I, Vrbic S. Ekspresija CD44, CD117, SOX2 i OCT3/4 kod karcinoma jajnika. Zbornik radova 50. Kancerološke nedelje Kancerološke sekcije SLD, 2013: 27.
  
  
  16. Dimov I, Ugrenovic S, Stojnev S, Kostic M, Tasic D, Stefanovic V. Nanog as the potential marker of the cancer stem cells in the high grade glioma patients. Materia Medica 2012; 28(2):591.
  
  
  17. Krstić M, Mihailović D, Mijović Ž, VeličkovićLj, Stojnev S, Ristić A,  Živković N. Immunohistochemical study of mucins expression in gastric carcinoma. Materia Medica 2012; 28(2):603.
  
  
  18. Živkovic N, Mihailovic D, Petrovic S, Mijovic Z, Radovanovic A, Stojanovic S, RisticPetrovic A, Stojnev S. Renal angiomyolipoma - case report. Materia Medica 2012; 28(2):618.
  
  
  19. Stojnev S, Ristić A, Ljubisavljević S. Polipoza nosa i antigenska indukcija sluzokože nosa. Zbornik sažetaka, 48. Kongres studenata medicinskih nauka Srbije sa internacionalnim učešćem, Kopaonik 2007; 203.
  
  
  20. Stojnev S, Ljubisavljević S, Ristić A. Procena kvaliteta života u obolelih od diabetes melitusa tip 2. Zbornik sažetaka, 47. Kongres studenata medicinskih nauka Srbije i Crne gore, Lepenski Vir 2006; (CD ISBN 86-7197-240-2).
  
  
  21. Ljubisavljević S, Stevanović I, Stojnev S, Zdravković I. Uticaj pušenja na ekspresiju procesa lipidne peroksidacije u pacijenata na hemodijalizi. Zbornik sažetaka, 47. Kongres studenata medicinskih nauka Srbije i Crne gore, Lepenski Vir 2006; (CD ISBN 86-7197-240-2).
  
  
  22. Stojnev S, Ljubisavljević S, Ristić A. Procena različitih metoda za dijagnostikovanje mikroalbuminurije u dijabetes mellitusu tip 1. Zbornik sažetaka, 46. Kongres studenata medicine i stomatologije Srbije i Crne Gore, Kotor 2005; 162.